Skip to main content

Corporate insider profile

Jason Lettmann Insider Trades

Latest reported as CHIEF EXECUTIVE OFFICER of ALX ONCOLOGY HOLDINGS INC (ALXO).

Purchase filings
0
Reported companies
1
Net open-market value
-$4,303.90
Latest transaction
Aug 17, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 17, 2026ALX ONCOLOGY HOLDINGS INC (ALXO)CHIEF EXECUTIVE OFFICERSale2,230$1.93$4,304